Jushi Holdings (JUSHF) Total Debt (2021 - 2026)
Jushi Holdings (JUSHF) posted quarterly Total Debt of $263.6 million for Q2 2026, up 27.35% year-over-year from $207.0 million in Q2 2025, and up 7.94% quarter-over-quarter from $244.2 million in Q1 2026.
Jushi Holdings (JUSHF) Total Debt (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has reported Total Debt for 6 consecutive years, with $263.6 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Total Debt rose 27.35% year-over-year to $263.6 million; the TTM figure through Jun 2026 stood at $263.6 million (up 27.35% YoY), while the FY2025 annual figure was $212.5 million, up 12.44% from the prior year.
- Total Debt climbed to $263.6 million in Q2 2026 per JUSHF's latest filing, from $244.2 million in the prior quarter.
- Across five years, Total Debt topped out at $299.1 million in Q4 2023 and bottomed at $186.0 million in Q2 2022.
- Historically, Total Debt has averaged $224.1 million across 5 years, with a median of $212.4 million in 2024.
- Annual changes were most pronounced in 2022 — Total Debt soared 57.14% — and 2024, when it slumped 36.82%.
- Jushi Holdings' Total Debt stood at $198.0 million in 2022, then jumped by 51.07% to $299.1 million in 2023, then plunged by 36.82% to $189.0 million in 2024, then climbed by 12.44% to $212.5 million in 2025, then gained by 24.07% to $263.6 million in 2026.
- Business Quant data shows JUSHF's Total Debt at $263.6 million in Q2 2026, $244.2 million in Q1 2026, and $212.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | -5.81 Bn |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 16.59 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 31.47 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 13.35 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 3.92 Bn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 760.00 Mn |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn | 263.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 263.62 Mn |
| Mar 31, 2026 | 244.24 Mn |
| Dec 31, 2025 | 212.47 Mn |
| Sep 30, 2025 | 253.46 Mn |
| Jun 30, 2025 | 207.00 Mn |
| Mar 31, 2025 | 200.75 Mn |
| Dec 31, 2024 | 188.97 Mn |
| Sep 30, 2024 | 187.27 Mn |
| Jun 30, 2024 | 212.39 Mn |
| Mar 31, 2024 | 286.93 Mn |
| Dec 31, 2023 | 299.07 Mn |
| Sep 30, 2023 | 247.71 Mn |
| Jun 30, 2023 | 228.22 Mn |
| Mar 31, 2023 | 193.34 Mn |
| Dec 31, 2022 | 197.97 Mn |
| Sep 30, 2022 | 199.90 Mn |
| Jun 30, 2022 | 186.00 Mn |
| Dec 31, 2021 | 125.98 Mn |